U.S. markets closed
  • S&P Futures

    3,853.75
    +14.75 (+0.38%)
     
  • Dow Futures

    31,627.00
    +162.00 (+0.51%)
     
  • Nasdaq Futures

    12,673.50
    +9.75 (+0.08%)
     
  • Russell 2000 Futures

    2,211.80
    +22.10 (+1.01%)
     
  • Crude Oil

    67.45
    +1.36 (+2.06%)
     
  • Gold

    1,708.00
    +9.50 (+0.56%)
     
  • Silver

    25.73
    +0.44 (+1.73%)
     
  • EUR/USD

    1.1927
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.5540
    +0.0040 (+0.26%)
     
  • Vix

    24.66
    -3.91 (-13.69%)
     
  • GBP/USD

    1.3846
    +0.0018 (+0.13%)
     
  • USD/JPY

    108.4170
    +0.0350 (+0.03%)
     
  • BTC-USD

    51,633.99
    +2,556.15 (+5.21%)
     
  • CMC Crypto 200

    1,041.32
    +98.15 (+10.41%)
     
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • Nikkei 225

    29,142.66
    +278.34 (+0.96%)
     

Top Ranked Momentum Stocks to Buy for October 3rd

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 3rd:

Aclaris Therapeutics, Inc. (ACRS): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

Aclaris Therapeutics, Inc. Price and Consensus

Aclaris Therapeutics, Inc. Price and Consensus
Aclaris Therapeutics, Inc. Price and Consensus

Aclaris Therapeutics, Inc. price-consensus-chart | Aclaris Therapeutics, Inc. Quote

Aclaris Therapeutics' shares gained 7.4% over the last one month compared to S&P 500’s fall of 0.6%. The company possesses a Momentum Score of A.

Aclaris Therapeutics, Inc. Price

Aclaris Therapeutics, Inc. Price
Aclaris Therapeutics, Inc. Price

Aclaris Therapeutics, Inc. price | Aclaris Therapeutics, Inc. Quote

Allegiant Travel Company (ALGT): This leisure travel company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

Allegiant Travel Company Price and Consensus

Allegiant Travel Company Price and Consensus
Allegiant Travel Company Price and Consensus

Allegiant Travel Company price-consensus-chart | Allegiant Travel Company Quote

Allegiant Travel's shares gained 5.4% over the last one month. The company possesses a Momentum Score of A.

Allegiant Travel Company Price

Allegiant Travel Company Price
Allegiant Travel Company Price

Allegiant Travel Company price | Allegiant Travel Company Quote

Ally Financial Inc. (ALLY): This provider of financial products and services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.

Ally Financial Inc. Price and Consensus

Ally Financial Inc. Price and Consensus
Ally Financial Inc. Price and Consensus

Ally Financial Inc. price-consensus-chart | Ally Financial Inc. Quote

Ally Financial’s shares gained 1.9% over the last one month. The company possesses a Momentum Score of B.

Ally Financial Inc. Price

Ally Financial Inc. Price
Ally Financial Inc. Price

Ally Financial Inc. price | Ally Financial Inc. Quote

Arcosa, Inc. (ACA): This provider of infrastructure-related products and solutions has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Arcosa, Inc. Price and Consensus

Arcosa, Inc. Price and Consensus
Arcosa, Inc. Price and Consensus

Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote

Arcosa’s shares gained 4.3% over the last one month. The company possesses a Momentum Score of B.

Arcosa, Inc. Price

Arcosa, Inc. Price
Arcosa, Inc. Price

Arcosa, Inc. price | Arcosa, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 7 stocks to watch. The report is only available for a limited time.

See 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Ally Financial Inc. (ALLY) : Free Stock Analysis Report
 
Allegiant Travel Company (ALGT) : Free Stock Analysis Report
 
Aclaris Therapeutics, Inc. (ACRS) : Free Stock Analysis Report
 
Arcosa, Inc. (ACA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research